Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer

BACKGROUND: HER2/neu overexpression is linked to promotion of angiogenesis in breast cancer. We therefore tested the activity of the combination of Trastuzumab with metronomic, low dose chemotherapy with cyclophosphamide (CTX) and methotrexate (MTX) in metastatic breast cancer (MBC). METHODS: Betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Orlando, Laura, Cardillo, Anna, Ghisini, Raffaella, Rocca, Andrea, Balduzzi, Alessandra, Torrisi, Rosalba, Peruzzotti, Giulia, Goldhirsch, Aron, Pietri, Elisabetta, Colleoni, Marco
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1579231/
https://www.ncbi.nlm.nih.gov/pubmed/16978400
http://dx.doi.org/10.1186/1471-2407-6-225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1579231/
https://www.ncbi.nlm.nih.gov/pubmed/16978400
http://dx.doi.org/10.1186/1471-2407-6-225

Ejemplares similares